DA-EPOCH-R Induction Followed by Nivolumab Consolidation in Newly Diagnosed MYC, BCL2 and/or BCL6 Rearranged HGBL

Clinical trial NCT03620578 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03620578
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Hodgkin Lymphoma Lymphoma, B-Cell High-grade B-cell Lymphoma MYC Translocation BCL-2 Translocation

Start date: 2018-08-01
Primary completion: 2024-01-30
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.